Advertisement
mucoderm® is an acellular native collagen matrix that offers a safe alternative to autologous soft tissue transplants in a diverse range of soft tissue grafting indications. During the process all non-collagenous proteins and cells as well as potential immunogens, bacteria and viruses are removed, resulting in a three-dimensional, stable matrix, which consists of collagen type I and III. Due to its high porosity and natural collagen structure, mucoderm® provides an excellent scaffold for ingrowing blood vessels and cells, thus supporting a fast revascularization and tissue integration. After implantation mucoderm® is continuously remodeled into patients own soft tissue. The simultaneous degradation of the matrix leads to a complete substitution of mucoderm® by the newly formed host tissue within about 6-9 months.
Hall 4.1 | A099